PDS Biotechnology Corporation — Quarterly Financial Statistics (NASDAQ:PDSB) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -8 M-8.23 M-9.03 M-9.1 M-5.92 M -32.28 M Cash from investing activities ————— — Cash from financing activities 17.22 K172.78 K7.32 M995.94 K241.2 K 8.73 M Free cash flow -8 M-8.23 M-9.03 M-9.1 M-5.92 M -32.28 M

뉴스

PDS 바이오텍, 3상 시험 변경… 신속 승인 경로 추가

PDS Biotech amends Phase 3 trial to add accelerated approval path

PDS Biotech reports 9.6-month progression-free survival in prostate cancer study

PDS 바이오, 암 면역치료제 PDS0101 특허 확보

PDS Biotech secures patent for cancer immunotherapy PDS0101

PDS Biotech, FDA 회의 후 주가 급등: 승인 가속화 기대

PDS Biotech stock soars after FDA meeting provides accelerated approval path

PDS 바이오텍, 3상 암 임상시험 수정안 제출

PDS Biotech submits amended protocol for phase 3 cancer trial

PDS Biotech secures new patent for cancer immunotherapy in Japan

PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why

PDS Biotech, FDA와 신속 승인 논의